Devices › Separator, automated, blood cell and plasma, therapeutic
Device brand name · Automated blood cell separator
Trima Accel Enhanced Plt Pls Rbc Set: medical device reports filed with FDA
167 reports name it, 2011–2012. Manufacturer given most often on reports: Caridianbct. Product code LKN.
- 167
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 79%
- classified as malfunction
- 53.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
167 medical device reports received by FDA name the brand "Trima Accel Enhanced Plt Pls Rbc Set" (automated blood cell separator); the manufacturer given most often on reports is Caridianbct; received from April 2011 to June 2012. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (79%), other (20.4%) and injury (0.6%); across all separator, automated, blood cell and plasma, therapeutic reports (product code LKN) death is recorded in 3.8% and malfunction in 53.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are high test results (71.9%), device operates differently than expected (16.8%) and incorrect or inadequate test results (6%). The patient problems coded most often are no patient involvement, dizziness and needle stick/puncture. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Trima Accel Enhanced Plt Pls Rbc Set was received in the five years to August 2026; the latest was received in June 2012.
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,776 reports carrying product code LKN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| High test results | 120 | 71.9% | 11.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 28 | 16.8% | 5.6% |
| Incorrect or inadequate test results | 10 | 6% | 0.6% |
| Insufficient device problem information | 6 | 3.6% | 20.9% |
| Breakthe device broke | 3 | 1.8% | 1% |
| Improper or incorrect procedure or method | 2 | 1.2% | 6.2% |
| Air leak | 1 | 0.6% | 3.3% |
| Device contamination with body fluid | 1 | 0.6% | 0.3% |
| Device displays incorrect message | 1 | 0.6% | 7.8% |
| High readingsreadings were too high | 1 | 0.6% | 0% |
| Inaccurate delivery | 1 | 0.6% | 0.1% |
| Incorrect measurementthe device measured wrongly | 1 | 0.6% | 0% |
| Loose or intermittent connection | 1 | 0.6% | 0.1% |
| Low test results | 1 | 0.6% | 0.1% |
| Misassembly by users | 1 | 0.6% | 0.5% |
| Output problem | 1 | 0.6% | 0.2% |
| Protective measures problem | 1 | 0.6% | 0.1% |
| Volume accuracy problem | 1 | 0.6% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 59 | 35.3% |
| Dizzinesslight-headedness or unsteadiness | 2 | 1.2% |
| Needle stick/puncture | 2 | 1.2% |
| Test result | 2 | 1.2% |
| Apnea | 1 | 0.6% |
| Discomfortdiscomfort | 1 | 0.6% |
| Dyspneashortness of breath | 1 | 0.6% |
| Fainting | 1 | 0.6% |
| Fever | 1 | 0.6% |
| Headachehead pain | 1 | 0.6% |
| Hemolysis | 1 | 0.6% |
| Occlusion | 1 | 0.6% |
| Palpitationsawareness of the heartbeat | 1 | 0.6% |
| Reactiona reaction, type not specified | 1 | 0.6% |
| Thrombus | 1 | 0.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Trima Accel Enhanced Plt Pls Rbc Set | Product code LKN | All MAUDE reports |
|---|---|---|---|
| Reports | 167 | 2,776 | 26,136,888 |
| Share of that pool | — | 6% | 0% |
| Classified as death, per 1,000 reports | 0 | 38 | 9 |
| Classified as injury | 0.6% | 22.6% | 36.2% |
| Classified as malfunction | 79% | 53.1% | 62.3% |
| Filed by the manufacturer | 100% | 95.5% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LKN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Spectra Optia | 2,037 | 70 | 4.9% |
| Teruflex Blood Bag System | 368 | 0 | 0% |
| Cobe Spectra Blood Collection | 288 | 0 | 4.2% |
| Trima Accel | 4,241 | 89 | 0.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Trima Accel Enhanced Plt Pls Rbc Set reports
How many FDA reports name Trima Accel Enhanced Plt Pls Rbc Set?
167 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (79%), other (20.4%) and injury (0.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
high test results (71.9%), device operates differently than expected (16.8%), incorrect or inadequate test results (6%), insufficient device problem information (3.6%) and break (1.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Trima Accel Enhanced Plt Pls Rbc Set was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.